Quest Diagnostics (DGX)
NYSEHealth CareDiagnostics & ResearchSnapshot 2026-07-07
$212.26-0.56%
Close 2026-07-07 · 1-day change
Reading DGX? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track DGX free→NYSEHealth CareDiagnostics & ResearchSnapshot 2026-07-07
Reading DGX? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track DGX free→QuarterlyIQ Insights · DGX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||||
| Revenues | 11,278.0 | 11,035.0 | 9,872.0 | 9,252.0 | 9,437.0 | 9,437.0 | 9,437.0 | 7,726.0 | 7,214.0 | 7,515.0 | 7,515.0 | 7,493.0 | 7,383.0 | 7,383.0 | 7,382.6 | 7,510.5 | 7,249.4 | 7,249.4 |
| Total Revenues | 10.0 | 13.0 | 25.0 | — | — | — | — | — | 7,214.0 | 7,515.0 | 7,515.0 | 7,493.0 | 7,383.0 | 7,383.0 | 7,382.6 | 7,510.5 | 7,249.4 | 7,249.4 |
| Cost of Revenues | 7,534.0 | 7,370.0 | 6,628.0 | 6,199.0 | 5,804.0 | 5,804.0 | 5,804.0 | 5,037.0 | 4,616.0 | 4,616.0 | 4,616.0 | 4,657.0 | 4,365.0 | 4,365.0 | 4,364.7 | 4,395.3 | 4,256.2 | 4,256.2 |
| Gross Profit | — | — | — | — | — | — | 3,633.0 | 2,689.0 | 2,605.0 | 2,899.0 | 2,899.0 | 2,836.0 | 2,798.0 | 3,018.0 | 3,017.9 | 3,115.2 | 3,051.7 | — |
| Operating Expenses & Income | ||||||||||||||||||
| Selling, General & Admin | 1,995.0 | 1,967.0 | 1,770.0 | 1,642.0 | 1,550.0 | 1,550.0 | 1,550.0 | 1,457.0 | 1,380.0 | 1,681.0 | 1,681.0 | 1,679.0 | 1,745.0 | 1,745.0 | 1,745.2 | 1,814.3 | 1,736.9 | 1,736.9 |
| Other Operating Expenses, Total | 12.0 | 12.0 | (1.0) | (41.0) | (9.0) | (9.0) | (9.0) | 95.0 | 13.0 | 13.0 | 13.0 | (11.0) | — | — | — | — | — | — |
| Operating Income | 1,609.0 | 1,556.0 | 1,346.0 | 1,262.0 | 1,971.0 | 1,971.0 | 1,971.0 | 1,231.0 | 1,277.0 | 1,277.0 | 1,277.0 | 1,399.0 | 1,201.0 | 1,201.0 | 1,200.8 | 995.0 | 1,222.4 | 1,222.4 |
| Earnings from Continuing Operations | ||||||||||||||||||
| Interest Expense | — | — | — | 163.0 | 166.0 | 166.0 | 166.0 | 180.0 | 144.0 | 144.0 | 144.0 | — | — | — | — | 173.3 | (185.5) | — |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 2.8 | 5.7 | — |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 170.6 | (191.2) | — |
| Other Non-Operating Income / Expenses | (233.0) | (238.0) | (171.0) | (132.0) | (87.0) | (87.0) | (87.0) | (155.0) | (191.0) | (191.0) | (191.0) | (296.0) | (133.0) | (133.0) | (132.4) | (138.8) | (171.7) | (171.7) |
| Asset Writedown | — | — | — | — | — | — | — | — | — | — | — | 16.0 | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | 1,376.0 | 1,318.0 | 1,175.0 | 1,130.0 | 1,884.0 | 1,884.0 | 1,884.0 | 1,076.0 | 1,086.0 | 1,086.0 | 1,086.0 | 1,103.0 | — | — | — | 856.2 | 1,050.7 | — |
| Income Tax Expense | 329.0 | 314.0 | 273.0 | 248.0 | 460.0 | 460.0 | 460.0 | 247.0 | 429.0 | 429.0 | 429.0 | 373.0 | 402.0 | 402.0 | 401.9 | 349.0 | 386.8 | 386.8 |
| Earnings from Continuing Operations | — | — | — | — | — | 1,499.0 | 1,499.0 | 886.0 | — | — | 696.0 | 753.0 | 666.0 | 666.0 | 666.5 | 507.2 | 663.9 | 663.9 |
| Net Income | ||||||||||||||||||
| Minority Interest | 51.0 | 54.0 | 50.0 | 54.0 | 68.0 | 68.0 | 68.0 | 48.0 | 51.0 | 51.0 | 51.0 | 44.0 | 36.0 | 36.0 | 36.4 | 35.1 | 31.7 | 31.7 |
| Net Income | 1,024.0 | 992.0 | 871.0 | 854.0 | 1,431.0 | 1,431.0 | 1,431.0 | 858.0 | 645.0 | 645.0 | 645.0 | 709.0 | 556.0 | 556.0 | 555.7 | 470.6 | 581.5 | 581.5 |
| Per Share | ||||||||||||||||||
| Basic EPS | 9.31 | 8.87 | 7.78 | 7.59 | 10.62 | 10.62 | 10.62 | 6.36 | 4.58 | 4.58 | 4.58 | 4.92 | 3.49 | 3.49 | 3.49 | 2.95 | 2.99 | 2.99 |
| Diluted EPS | 9.14 | 8.75 | 7.69 | 7.49 | 10.47 | 10.47 | 10.47 | 6.28 | 4.51 | 4.51 | 4.51 | 4.87 | 3.46 | 3.46 | 3.46 | 2.92 | 2.96 | 2.96 |
| Revenue per Share | 0.09 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | — | — | 0.71 | 0.66 | 0.62 | 0.56 | 0.53 | 0.53 | 1.65 | 1.65 | 1.52 | 0.81 | 0.81 | 0.81 | 0.47 | 0.40 | 0.40 |
| Basic Weighted Avg Shares | 110.0 | 111.0 | 111.0 | 112.0 | 134.0 | 134.0 | 134.0 | 134.0 | 140.0 | 140.0 | 140.0 | 144.0 | 159.0 | 159.0 | 158.6 | 158.7 | 194.3 | — |
| Diluted Weighted Avg Shares | 112.0 | 113.0 | 113.0 | 113.0 | 136.0 | 136.0 | 136.0 | 136.0 | 142.0 | 142.0 | 142.0 | 145.0 | 160.0 | 160.0 | 160.1 | 160.2 | 196.0 | — |
| Supplemental | ||||||||||||||||||
| EBITDA | — | 2,126.0 | 1,839.0 | 1,701.0 | 2,332.0 | 2,332.0 | 2,332.0 | 1,560.0 | 1,526.0 | 1,526.0 | 1,526.0 | 1,703.0 | 1,488.0 | 1,488.0 | 1,487.4 | 1,276.2 | 1,487.0 | 1,487.0 |
| EBIT | 1,609.0 | 1,556.0 | 1,346.0 | 1,262.0 | 1,971.0 | 1,971.0 | 1,971.0 | 1,231.0 | 1,277.0 | 1,277.0 | 1,277.0 | 1,399.0 | 1,201.0 | 1,201.0 | 1,200.8 | 995.0 | 1,222.4 | 1,222.4 |
| Effective Tax Rate | 23.9% | 23.8% | 23.2% | 21.9% | 24.4% | 24.4% | 24.4% | 23.0% | 39.5% | 39.5% | 39.5% | 33.8% | — | — | — | 40.8% | 36.8% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.